Wolverine Trading, LLC Akero Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 15, 2023	BUY	$41.19 - $52.25 $177,117 - $224,675	4,300 Added 29.86%	18,700 $945,000
Q2 2023 Aug 23, 2023	BUY	$36.89 - $56.88 $206,584 - $318,528	5,600 Added 63.64%	14,400 $672,000
Q1 2023 May 15, 2023	SELL	$37.27 - $50.24 $137,899 - $185,888	-3,700 Reduced 29.6%	8,800 $333,000
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $418,000 - $685,000	12,500 New	12,500 $685,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.43B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.